abstract |
Described herein are tripartite androgen receptor ablation agents (AREs), pharmaceutical compositions and medicaments comprising such AREs, methods and uses for such AREs and compositions and medicaments, and androgen receptor signals. Disclosed are methods and uses for AREs and compositions and medicaments for treating transmission-mediated conditions, diseases or disorders. [Selection diagram] None |